Erşahin, T. Et Al. 2015. COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA: A SYSTEMS BIOLOGY PERSPECTIVE ON THE SYNERGISTIC ANTITUMOR ACTIVITY OF SORAFENIB WITH PI3K/AKT PATHWAY INHIBITORS. 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver , (Vienna, Austria), 464.

Erşahin, T., Tunçbağ, N., Acar, A. C., & Atalay, R., (2015). COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA: A SYSTEMS BIOLOGY PERSPECTIVE ON THE SYNERGISTIC ANTITUMOR ACTIVITY OF SORAFENIB WITH PI3K/AKT PATHWAY INHIBITORS . 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver (pp.464). Vienna, Austria

Erşahin, Tülin Et Al. "COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA: A SYSTEMS BIOLOGY PERSPECTIVE ON THE SYNERGISTIC ANTITUMOR ACTIVITY OF SORAFENIB WITH PI3K/AKT PATHWAY INHIBITORS," 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver, Vienna, Austria, 2015

Erşahin, Tülin Et Al. "COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA: A SYSTEMS BIOLOGY PERSPECTIVE ON THE SYNERGISTIC ANTITUMOR ACTIVITY OF SORAFENIB WITH PI3K/AKT PATHWAY INHIBITORS." 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver , Vienna, Austria, pp.464, 2015

Erşahin, T. Et Al. (2015) . "COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA: A SYSTEMS BIOLOGY PERSPECTIVE ON THE SYNERGISTIC ANTITUMOR ACTIVITY OF SORAFENIB WITH PI3K/AKT PATHWAY INHIBITORS." 50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver , Vienna, Austria, p.464.

@conferencepaper{conferencepaper, author={Tülin Erşahin Et Al. }, title={COMBINATION THERAPY FOR HEPATOCELLULAR CARCINOMA: A SYSTEMS BIOLOGY PERSPECTIVE ON THE SYNERGISTIC ANTITUMOR ACTIVITY OF SORAFENIB WITH PI3K/AKT PATHWAY INHIBITORS}, congress name={50th International Liver Congress of the European-Association-for-the-Study-of-the-Liver}, city={Vienna}, country={Austria}, year={2015}, pages={464} }